The NHS Cambridgeshire and Peterborough system intensive collaboration to review the national framework for direct-acting oral anticoagulant (DOACs) and optimise the benefits for our population and system.
The Medicines optimisation team (MOT) took the lead in developing a delivery plan, coordinating our system approach and facilitated collaboration with primary and secondary care (three trusts) and other stakeholders.
The rate increase in edoxaban prescribing was from March 2022 – 3,762 items to March 2023 12,288 items.
